Brought to you by 
Shanghai Pharmaceuticals completes $1.99bn IPO on HKSE
30 Apr 2012
Executive Summary
After months of speculation as to the offering size and price, China's second-largest drug distributor Shanghai Pharmaceuticals Holding Co. Ltd. has netted HKD15.5bn ($1.99bn)--including the overallotment--in an IPO on the Hong Kong Exchange, making it the second-biggest pharmaceutical IPO to date. In the global offer, the company sold approximately 696mm shares--representing over 25% of the company’s enlarged issued share capital--at HKD23.00. The anticipated range was HKD21.80-26.00.
Deal Industry
- Distributors
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shanghai Pharmaceuticals completes $1.99bn IPO on HKSE
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice